Volume 62, Issue 4, Pages (October 2012)

Slides:



Advertisements
Similar presentations
Early Detection of Prostate Cancer in 2007
Advertisements

The PSA Era is not Over for Prostate Cancer
Volume 69, Issue 3, Pages (March 2016)
Volume 57, Issue 1, Pages (January 2010)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 52, Issue 3, Pages (September 2007)
Testosterone Therapy in Men With Prostate Cancer
Volume 56, Issue 6, Pages (December 2009)
Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer  Marisa Warmuth,
Volume 53, Issue 4, Pages (April 2008)
Volume 54, Issue 6, Pages (December 2008)
Volume 72, Issue 5, Pages (November 2017)
Volume 61, Issue 5, Pages (May 2012)
Volume 74, Issue 2, Pages (August 2018)
Volume 64, Issue 4, Pages (October 2013)
Volume 66, Issue 3, Pages (September 2014)
Let the Games Begin (with EAU Approval)
Volume 61, Issue 2, Pages (February 2012)
Prostate Cancer Epidemic in Sight?
Volume 65, Issue 6, Pages (June 2014)
Volume 63, Issue 4, Pages (April 2013)
Daily Administration of Phosphodiesterase Type 5 Inhibitors for Urological and Nonurological Indications  Anthony J. Bella, Ling X. DeYoung, Mussa al-Numi,
Tumour Grade, Treatment, and Relative Survival in a Population-based Cohort of Men with Potentially Curable Prostate Cancer  Sam Ladjevardi, Gabriel Sandblom,
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 9, Issue 5, Pages (May 2008)
Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey  John B. McKinlay, Carol L. Link  European.
Volume 54, Issue 4, Pages (October 2008)
Elizabeth K. Bancroft, Rosalind A. Eeles
Volume 52, Issue 3, Pages (September 2007)
Volume 63, Issue 6, Pages (June 2013)
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Volume 69, Issue 3, Pages (March 2016)
Prostate Cancer Detection: A View of the Future
Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance  Adam B. Weiner, Ruth Etzioni, Scott E. Eggener 
Volume 68, Issue 3, Pages (September 2015)
Volume 56, Issue 2, Pages (August 2009)
Volume 69, Issue 3, Pages (March 2016)
Volume 60, Issue 4, Pages (October 2011)
Laurent Boccon-Gibod  European Urology Supplements 
Prostate Cancer Epidemic in Sight?
The PSA Era is not Over for Prostate Cancer
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 53, Issue 4, Pages (April 2008)
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Volume 71, Issue 1, Pages (January 2017)
Volume 65, Issue 6, Pages (June 2014)
Tillmann Loch, Pat Fox Fulgham  European Urology 
Volume 68, Issue 4, Pages (October 2015)
Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels
Volume 50, Issue 5, Pages (November 2006)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 71, Issue 3, Pages (March 2017)
Testicular Cancer Variations in Time and Space in Europe
Volume 53, Issue 1, Pages (January 2008)
Volume 72, Issue 5, Pages (November 2017)
Volume 59, Issue 4, Pages (April 2011)
Volume 15, Issue 10, Pages (September 2014)
European Urology is “Your” Journal
Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg 
Volume 74, Issue 6, Pages (December 2018)
Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.
The Comparability of Models for Predicting the Risk of a Positive Prostate Biopsy with Prostate-Specific Antigen Alone: A Systematic Review  Fritz Schröder,
Volume 52, Issue 6, Pages (December 2007)
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson 
Volume 53, Issue 2, Pages (February 2008)
Systematic Review of Complications of Prostate Biopsy
Volume 74, Issue 6, Pages (December 2018)
Volume 54, Issue 3, Pages (September 2008)
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Volume 62, Issue 4, Pages 649-655 (October 2012) Predictors of Attendance for Prostate-Specific Antigen Screening Tests and Prostate Biopsy  Kerry N.L. Avery, Chris Metcalfe, Kavita Vedhara, J. Athene Lane, Michael Davis, David E. Neal, Freddie C. Hamdy, Jenny L. Donovan, Jane M. Blazeby  European Urology  Volume 62, Issue 4, Pages 649-655 (October 2012) DOI: 10.1016/j.eururo.2011.12.059 Copyright © 2012 European Association of Urology Terms and Conditions

Fig. 1 Flowchart of study recruitment and data analyses. PSA=prostate-specific antigen. European Urology 2012 62, 649-655DOI: (10.1016/j.eururo.2011.12.059) Copyright © 2012 European Association of Urology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.